Innovation Pharmaceuticals to Present Brilacidin for Inflammatory Bowel Disease at Inaugural IBD Innovate 2018 Conference Hosted by the Crohns & Colitis Foundation

BEVERLY Mass. Sept. 05 2018 GLOBE NEWSWIRE Innovation Pharmaceuticals OTCQBIPIX the Company a clinical stage biopharmaceutical company announced today that the Company has been invited to present on the planned continued development of Brilacidin for In...